NICHOLAS MIETUS: Open Payments
NPI 1306352422 · BARTLESVILLE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,957 in 134 payments from 16 companies in 2025. Trend: 2023 $1,618 · 2024 $3,505 · 2025 $2,957
Food & beverage: $2,862Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $496 |
| ABBVIE INC. | 19 | $473 |
| Regeneron Healthcare Solutions, Inc. | 14 | $423 |
| PFIZER INC. | 19 | $263 |
| Arcutis Biotherapeutics, Inc. | 13 | $256 |
| Lilly USA, LLC | 7 | $204 |
| Amgen Inc. | 7 | $178 |
| MAYNE PHARMA COMMERCIAL LLC | 11 | $146 |
| Organon LLC | 7 | $138 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
Products named: TREMFYA, DUPIXENT, RINVOQ, Zoryve, CIBINQO, SKYRIZI, OTEZLA, EBGLYSS.
Industry payments across OK — which companies pay providers there.
